Chi3l1 is significantly correlated with AD core biomarkers such as tau protein and amyloid beta (Aβ), whereas core biomarkers of neurodegeneration, such as tau protein, can accurately distinguish different neurodegenerative diseases, such as Alzheimer’s disease dementia and frontotemporal dementia [159,160]. This evidence concerns the gene MAPT and frontotemporal dementia.